Introduction
The incidence of Lyme disease (LD) in dogs and human beings is increasing and endemic regions are expanding in many regions of North America and Europe (Mead et al., 2011; Tseng et al., 2015; Sykes and Makiello, 2016) . The primary etiological agent of LD in North America is Borrelia burgdorferi (Burgdorfer et al., 1982; Benach et al., 1983) while in Europe and Asia, B. burgdorferi, B. garinii, B. bavariensis, and B. afzelii are the main species associated with disease (Baranton et al., 1992; Marconi and Garon, 1992; Margos et al., 2013) . We refer to this group of bacterial species collectively as the 'LD spirochetes'. LD is transmitted among its diverse mammalian reservoirs and to its incidental hosts (human beings and dogs) by Ixodes ricinus complex ticks (Barbour and Hayes, 1986) . The number of counties in the USA where I. scapularis or I. pacificus populations are now established has risen by 49% since 1996 (Eisen et al., 2016) . In 2014, the Centers for Disease Control and Prevention reported that the number of LD cases each year in humans is between 300,000 and 450,000 (Hinckley et al., 2014) . Data compiled by the Companion Animal Parasitic Council (CAPC) indicate moderate to high risk for LD in dogs in much of the Eastern half of the US and Southern Canada. In 2015, 250,880/4,062,155 (6.2%) tested dogs in the US were antibody (Ab) positive for LD. As detailed by CAPC 1 , these numbers represent about 30% of the total, bringing the probable number of Ab positive tests in dogs in 2015 to approximately 800,000.
OspC, an essential virulence factor of the LD spirochetes, has been a major focus of efforts to develop new LD vaccines and diagnostic assays (Grimm et al., 2004; Tilly et al., 2006; Earnhart et al., 2010) . OspC production is stimulated in feeding ticks and maintained through early stage infection in mammals, in which it is an immunodominant antigen (Dressler et al., 1993; Fung et al., 1994;  Contents lists available at ScienceDirect
The Veterinary Journal j o u r n a l h o m e p a g e : w w w. e l s e v i e r. c o m / l o c a t e / t v j l Fingerle et al., 1995; Schwan et al., 1995; Gilmore and Piesman, 2000; Pal et al., 2004) . The high level expression of OspC in fed ticks and mammals and its antigenicity during early infection are properties that support the use of OspC (or OspC derived proteins) in vaccines and as a diagnostic antigen (Schwan, 2003; Earnhart et al., 2005; Baum et al., 2014) . However, OspC is a highly variable protein with~30 distinct variants or 'types' having been defined (Brisson and Dykhuizen, 2004; Earnhart and Marconi, 2007c; Brisson et al., 2012; Rhodes et al., 2013) . OspC types are differentiated by letter designations (e.g. type A, type B).
Different conclusions have been reached regarding the identity of the antigenic determinants of OspC that stimulate Ab responses during infection or upon vaccination with either LD bacterins or recombinant OspC based proteins (Earnhart et al., 2005; Callister et al., 2015) . Understanding the antigenic structure of OspC is essential for the translational applications indicated above. Studies in mice and humans suggest that sequence variation, particularly within the coding sequence of the variable loop 5 (L5) and α helix 5 (H5) epitopes of OspC, leads to highly specific Ab responses during infection (Earnhart et al., 2005; Buckles et al., 2006; Marconi, 2007a, 2007b; Baum et al., 2016) . Other studies implicate conserved domains of OspC, such as the C7 domain, as immunodominant (Mathiesen et al., 1998b; Gilmore and Mbow, 1999) . C7, which has also been referred to as the C10 or pepC10 domain, consists of the C-terminal residues of OspC (Mathiesen et al., 1998a; Wang et al., 1999; Earnhart et al., 2014) . In this paper, we use the designation C7/C10 for this domain. It has also been suggested that OspC production patterns may be uniquely different in dogs compared to other mammals (Lovrich et al., 2007; Callister et al., 2015) .
In this study, we assessed the specificity and evolution of IgG responses to OspC in the context of natural canine infection, experimental infection in mice and upon hyperimmunization of rabbits with recombinant OspC proteins. In addition, since B. burgdorferi cell lysates are the basis for LD bacterin vaccines, we also assessed the production levels of OspC during in vitro cultivation. The results of this study highlight the importance of considering OspC production levels and diversity in vaccine design and diagnostic assay interpretation.
Materials and methods

Bacterial strains, cultivation and serum samples
All strains (Table 1 ) were cultivated in BSK-H media with 6% rabbit serum (SigmaAldrich; 37°C; 5% CO2) with 100× antibiotic mix (phosphomycin, rifampicin and amphotericin B; Sigma-Aldrich) as required. Growth was monitored by dark field microscopy. Canine patient serum samples were obtained on a fee for service basis. Information on each dog is presented in Table 2 . All dogs were SNAP4Dx (IDEXX) positive for C6 Ab. A subset that was OspC Ab positive, as determined by ELISA (data not shown) using several previously developed OspC epitope based chimeric proteins referred to as chimeritopes (Earnhart and Marconi, 2007b) was selected for further analyses.
Murine studies
Mid-log phase B. burgdorferi strains B31MI, LDP56 and LDP84 cells were recovered by centrifugation, washed with phosphate buffered saline (PBS) and 1 × 10 5 cells were needle inoculated into C3h-HeJ mice (n = 5 per group; Jackson Laboratories) (McDowell et al., 2001 ). Blood was collected from B31MI infected mice at weeks 0, 2, 4, 6 and 12 by tail nick. Blood was collected from LDP56 and LDP84 infected mice at weeks 0 and 4. Mice were euthanazed at either week 4 or 12 and blood was collected by cardiac puncture. Serum was harvested by standard methods. All animal experiments were conducted following the Guide for the Care and Use of Laboratory Animals (8th edition) and in accordance with protocols peer reviewed and approved by VCU Institutional Animal Care and Use Committees and/or the Statens Serum Institute.
Generation of OspC recombinant proteins and antiserum
To generate OspC proteins (types A through N), each gene (minus the leader peptide) was PCR amplified (Pfu polymerase) from the appropriate isolate (Table 1) . The PCR primers (Earnhart et al., 2005 (Earnhart et al., , 2010 were designed for ligase independent cloning (LIC) into the pET46Ek-LIC (Novagen). The resulting plasmids were used to generate recombinant proteins in E. coli (Miller et al., 2012) . The His-tagged proteins were purified using a Ni-Affinity column and an AKTA purification system (GE Healthcare) (Miller et al., 2012) . Protein concentrations were determined using the BCA Protein Assay Kit (Thermo Scientific). Antiserum to each purified protein was generated in New Zealand white rabbits (Statens Serum Institute) (Theisen, 1996) .
Dot blot, SDS-PAGE and immunoblot analyses
Immunoblot strips harboring the purified OspC proteins were generated using the Bio-Dot Apparatus (Bio-Rad). Protein (100 ng; 1× Tris buffered saline, TBS) was added to each well and the proteins were adhered to the nitrocellulose membranes under gravity flow. After washing three times with TBS, the membranes were removed and prepared for immunoblot analysis as described below. All membranes were stained with MemCode Reversible Protein Stain Kit (Thermo Scientific).
For sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE), recombinant proteins (500 ng) or B. burgdorferi B31MI cell lysate (0.33 optical density units at 600 nm, OD600, per 100 μL SDS-PAGE solution) was boiled, sonicated and fractionated on Any-kD precast Criterion gels (BioRad). One set of gels was stained with Coomassie brilliant blue and others were used to transfer proteins to polyvinylidene fluoride (PVDF) membranes using the Trans-Blot Turbo Transfer System (BioRad) and standard methods.
For the immunoblot analyses, nonspecific binding was blocked with 1× PBS containing 0.2% Tween-20 with 5% non-fat dry milk (PBSTM) for 1 h at room temperature (RT). The membranes were probed with canine or rabbit serum (1:500 or 1:15,000 in PBSTM, respectively) and incubated for 1 h at RT. Blots were washed three times with PBST and rabbit anti-dog IgG or goat anti-rabbit IgG conjugated to horseradish peroxidase (1:40,000 in PBSTM; Pierce) was added for 1 h at RT. After washing, bound IgG was detected using the SuperSignal West Pico Western blotting substrate (BioRad).
Indirect immunofluorescence assays
Indirect immunofluorescence assays (IFAs) were conducted as previously described (Earnhart et al., 2010) . Cells in PBS were placed on Superfrost Plus slides (Fisher Scientific), air dried, permeabilized with acetone, air dried and then nonspecific binding blocked by the addition of PBSTB (PBST with 3% bovine serum albumin). Slides were screened with mouse pre-immune serum, anti-OspC type A or anti-OspA antiserum (1:25,000 in PBSTB; 30 min), washed with PBST and bound IgG was detected with Alexa Fluor 568-conjugated goat anti-mouse IgG (Molecular Probes). The slides were washed, coverslips mounted (ProLong Gold; Molecular Probes), and bound Ab was detected by fluorescence microscopy (BX51; Olympus). (Tilly et al., 2006) ; encodes a second copy of the ospC gene on plasmid pBSV2G which also encodes gentamicin resistance (gen R )
Mouse anti-OspA served as a positive control, since OspA is expressed during in vitro cultivation. Pre-immune serum served as a negative control. Cells were also visualized by dark-field microscopy.
Results
Analysis of antibody responses to OspC in naturally infected dogs and in rabbits hyperimmunized with OspC proteins
To assess IgG responses to OspC in infected dogs, serum from 25 C6 Ab positive client owned dogs (SNAP4Dx) was screened against 14 OspC type proteins that represent the major variants found in North America (Earnhart and Marconi, 2007c; Cerar et al., 2016) . All dogs were seropositive for one or more OspC variants (Table 2 ; Fig. 1 ). Five reacted with a single OspC type, 13 reacted with two to five types and seven reacted with >10 types. The selective recognition of different OspC type proteins indicates that the immunodominant epitopes of OspC must reside within variable domains as opposed to conserved regions, such as the C7/C10 domain.
To assess the specificity of IgG responses to divergent OspC proteins, rabbits were hyperimmunized with OspC type A, B, C, D, H or K protein. Dot blot analyses revealed that immunization elicits OspC type specific Ab (Table 3) , supporting the data above, indicating that it is the variable domains of OspC, such as the L5 and/or H5 epitopes, which are immunodominant. These results are also consistent with earlier studies which demonstrated that immunization of mice with a single OspC protein elicits an Ab response with a narrow protective range (Gilmore et al., 1996; Bockenstedt et al., 1997) .
Analysis of OspC production levels by B. burgdorferi during in vitro cultivation
OspC concentration in a bacterin should be proportional to its contribution in eliciting bactericidal Ab responses in vaccinated animals. Since bacterins are produced using in vitro cultivated spirochetes, we assessed OspC production levels in several cultivated strains. SDS-PAGE gels of cell lysates were stained or immunoblotted and screened with anti-OspC type A antiserum ( Fig. 2A) . Strain B31-HE-OspC served as a positive control (Tilly et al., 2006) . Stained gels and immunoblots revealed low or variable levels of OspC production in B31, LDP56 and LDP74 strains (types A and K OspC, respectively). While variable staining of OspC with CBB stain (Alverson et al., 2003) could contribute to the interpretation of these data, we confirmed through staining of SDS-PAGE gels loaded with known amounts of each OspC protein that staining was equal (data not shown). As expected, high levels of OspC were detected in the B31-HE-OspC strain and no OspC was detected in B31ΔospC (Earnhart et al., 2010) . Strains LDP84 and DRI40h (OspC types C and F, respectively) (Earnhart et al., 2005; Rhodes et al., 2013) were weakly reactive with the anti-OspC type A antiserum due to both low expression (no visible OspC band upon staining) and weak recognition by anti-type A OspC antiserum. While a visible OspC band was observed in the DRI40h cell lysate upon staining, the protein was only weakly reactive with the anti-OspC type A antiserum. Analysis of OspC expression at the population level using IFAs revealed that only a subset of B31 cells produces OspC during cultivation, whereas all B31-HE-OspC cells produced OspC (Fig. 2B ). Immunoblot and IFA analyses of additional B. burgdorferi strains also revealed low level, sub-population dependent OspC production (data not shown). In contrast to OspC, OspA, which is known to be produced at high levels in vitro, was produced by all cells. Labrador retriever  DC  3  2  1  1  1  1  0  0  2  0  1  2  3  0  10  DB  Golden retriever  VA  4  2  3  3  3  3  4  3  3  3  3  3  3  3  14  MT  Yorkshire terrier  OH  1  1  3  0  0  3  0  0  0  0  1  0  0  0 The designation 'unknown' indicates that information about either the breed or state of origin was not available.
Table 3
Specificity of OspC Ab responses in hyperimmunized rabbits.
Specificity of the anti-OspC antibody response over the course of infection in mice
The evolution of the specificity of the OspC response during infection was assessed by screening OspC proteins with serum harvested at 0, 2, 4, 6 and 12 weeks from mice infected with B31MI (Fig. 3) . IgG to type A OspC was detected after week 2, with levels increasing out to week 12. While the Ab response was predominantly directed at OspC type A, and remained so throughout infection, weak cross reactivity with some other OspC types was observed. The Ab response in mice infected with LDP56 at week 4 was also type-specific. In contrast, Ab from mice infected with LDP84 (type C OspC) detected OspC types C, M, A and H. Comparative analysis of the L5 and H5 epitope sequences from OspC types C, M, A and H revealed that segments of the H5 epitope are conserved among OspC types M and C (85% amino acid identity over a 39 amino acid residue stretch), with the sequence differences localized within the N and C-terminal portions of the epitope. These differences would not be expected to interfere with cross reactivity of Ab against the type M and C H5 epitopes. In contrast, amino acid difference scattered throughout the H5 epitopes of OspC types A, C and H (69% identity) would presumably prevent Ab cross reactivity among these OspC types.
Discussion
Analyses of anti-OspC Ab responses in naturally infected dogs using divergent OspC proteins as detection antigens demonstrated significant variation in Ab responses among individual animals. Serum Ab from most infected dogs recognized a limited and variable subset of the most prevalent OspC types of North American LD isolates (Brisson and Dykhuizen, 2004; Earnhart and Marconi, 2007c; Strle et al., 2011) . This observation suggests that the dominant immuno-stimulatory determinants of OspC reside within variable domains. Others have postulated that conserved domains, specifically the C7/C10 domain, are immunodominant (Mathiesen et al., 1998a; Bacon et al., 2003; Porwancher et al., 2011; Arnaboldi et al., 2013) . However, if that were the case during canine infection, then all OspC variants screened with infection serum would be immunoreactive, regardless of the OspC type identity of the infecting strain(s). Additional evidence arguing against a significant contribution of C7/C10 in OspC Ab responses in canines came from allelic exchange replacement studies (Earnhart et al., 2014) . Replacement of the native ospC of B. burgdorferi B31 with an ospC that lacks the coding sequence for the C7/C10 domain had no effect on OspC Ab titers elicited during infection in mice. The weak antigenicity of the C7/C10 domain may indicate that it is not surface exposed on the OspC dimer. OspC atomic structures revealed C7/ C10 domain to be structurally unordered and its placement within OspC has not been defined (Eicken et al., 2001; Kumaran et al., 2001) .
Type-specific responses to OspC were also observed in rabbits immunized with different OspC type proteins. This observation was surprising, since one might expect buried or masked epitopes hidden in the context of the OspC dimer in viable cells to be accessible in recombinant proteins. The type-specific responses might reflect the highly stable and rigid structure of the OspC homodimer (Eicken et al., 2001; Kumaran et al., 2001) . It is noteworthy that the buried interface of the dimer constitutes 22% of the total surface accessible area of each monomer (Kumaran et al., 2001 ). The data above support the notion that a single OspC protein would be ineffective in stimulating a broadly protective Ab response.
It has been suggested that OspC present in bacterin vaccines may stimulate bactericidal Ab production (LaFleur et al., 2010) . However, OspC production during in vitro cultivation has been demonstrated by several research groups to be variable, low level and influenced by temperature (Schwan et al., 1995; Yang et al., 2000; Ohnishi et al., 2001; Ramamoorthy and Scholl-Meeker, 2001; Alverson et al., 2003; Mulay et al., 2009) . In this study, IFA and immunoblot analyses were employed to assess OspC production levels at the population level and among strains under standard cultivation conditions (37°C; BSK-H complete media). Immunoblotting revealed relatively low expression and IFA analyses demonstrated that only a fraction of cells in culture produce OspC. Hence, in the context of a bacterin vaccine, OspC constitutes a minor fraction of the total protein content. This may explain the low level of OspC targeting bactericidal Ab activity detected in the serum of dogs vaccinated with some LD bacterins (Lovrich et al., 2007) . LaFleur et al. sought to compensate for this through the use of a two strain bacterin consisting of strain S-1-10 and an ospAB -strain (LaFleur et al., 2010) . Strains that are unable to produce OspA either as a result of plasmid loss or genetic manipulation tend to produce more OspC than their wild-type counterparts (He et al., 2008; Srivastava and de Silva, 2008) . However, it remains to be determined if bacterins, Fig. 1 . The IgG response to OspC during natural infection with Borrelia burgdorferi in client owned dogs is OspC type specific. Fourteen recombinant OspC proteins were generated, purified and spotted onto nitrocellulose membranes using a dot blotter as detailed in the text. The type identity of each protein is indicated above the top panel (representative data are shown for six recombinant OspC proteins). The dot blot strips were screened with canine serum (indicated by an identification designation, ID) diluted 1:500, as detailed in the methods. Serum from an infection free dog (SNAP4Dx and OspC Ab negative; normal canine serum, NCS) served as a negative control. Twenty-five SNAP4Dx positive dogs were screened (representative data are shown with the complete data set presented in Table 2 ). To verify similar loading of each protein on the blot, one dot blot was stained with MemCode Reversible Protein Stain Kit (Thermo Scientific). The stained blot is indicated as 'stain'. such as that described above, do in fact harbor elevated amounts of OspC.
To determine if the Ab response to OspC remains type-specific as infection progresses, serum was collected over time from mice infected with B31MI (type A OspC) and used to screen a panel of eight OspC type proteins. Ab specificity remained largely specific for type A OspC, with only minor cross reactivity with other OspC proteins. Hence, even with cell turnover during infection which would liberate OspC from the membrane, conserved portions of the protein do not appear to elicit significant Ab responses.
The specificity of the OspC Ab response has implications for vaccine and diagnostic assay development. Based on the data presented here and in earlier studies (Earnhart and Marconi, 2009; Baum et al., 2014) , the broad protective capability of OspC based vaccines is clearly enhanced by the inclusion of multiple epitopes derived from diverse OspC type proteins. Consistent with earlier literature, broad protection cannot be achieved using a single OspC protein or cocktail of OspC proteins (Earnhart and Marconi, 2009) . A chimeric OspC epitope protein, referred to as a 'chimeritope' (Earnhart and Marconi, 2007b; Earnhart et al., 2007; Marconi and Earnhart, 2010) , has been developed and is a central component of Vanguard crLyme vaccine (Zoetis) 2 . OspC chimeritopes that consist almost entirely of L5 and H5 epitopes from diverse OspC variants have been demonstrated to elicit Ab with bactericidal activity against diverse strains (Earnhart and Marconi, 2007b; Earnhart et al., 2007) . Hence, it can be concluded that the C7/C10 domain is not strictly required for stimulating bactericidal Ab. Consistent with this, Lovrich et al. (2007) concluded that, while C7/C10 may stimulate bactericidal Ab in human beings, it does not in dogs.
The data presented here also suggest that a single OspC variant is insufficient to serve as a reliable diagnostic antigen; for example, as shown in Fig. 1 , canine TB is clearly seropositive for OspC types F and M. However, canine TB was negative or weakly positive for OspC types A, C, D and H. Hence, the use of an OspC variant other than types F and M as a diagnostic antigen would have resulted in a false negative diagnosis of dog TB. The importance of a multivalent approach can also be gleaned from several published studies that have assessed OspC as a diagnostic antigen. In one study where a single OspC protein (derived from strain 50772) served as a diagnostic antigen, a positive Ab response to OspC was detected in only 3/24 beagles infected by tick infestation, leading the authors to conclude that OspC is unreliable as a diagnostic antigen (Callister et al., 2015) . Another study used cell lysates of strain 297 (type E OspC) as the immobilized antigen to assess Ab responses to OspC in infected dogs (Callister et al., 2015) . While all dogs assessed in that study were culture positive for the LD spirochetes, only 1/14 was reported to be OspC Ab positive. In light of the fact that OspC is required for infection and is a proven early antigen, the lack of detection of an anti-OspC response in the aforementioned studies may instead be due to the use of a single OspC variant as the diagnostic antigen.
Conclusions
The antigenic properties of OspC suggest that careful consideration must be given to OspC diversity in the development of LD vaccines and diagnostic assays. One attractive approach eluded to above to address OspC diversity is the use of OspC chimeritopes, which have the potential to elicit broadly protective Ab responses that can both inhibit spirochete transmission from ticks to mammals and kill spirochetes that enter mammals. The potential exists to extend this technology to development of veterinary and human LD diagnostic antigens as well as in the development of a human LD vaccine.
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